191 related articles for article (PubMed ID: 37919172)
1. The stability and immunogenicity of formalin-inactivated Enterovirus A71 whole virion vaccine after ten years of low temperature storage.
Shen YS; Chow YH; Fang CY; Wu SR; Chen CH; Huang MH; Liao CL; Chiang JR; Liu CC
J Microbiol Immunol Infect; 2023 Dec; 56(6):1121-1128. PubMed ID: 37919172
[TBL] [Abstract][Full Text] [Related]
2. Immunological and biochemical characterizations of coxsackievirus A6 and A10 viral particles.
Liu CC; Guo MS; Wu SR; Lin HY; Yang YT; Liu WC; Chow YH; Shieh DB; Wang JR; Chong P
Antiviral Res; 2016 May; 129():58-66. PubMed ID: 26899790
[TBL] [Abstract][Full Text] [Related]
3. Molecular epidemiology and clinical features of hand, foot and mouth disease requiring hospitalization after the use of enterovirus A71 inactivated vaccine in chengdu, China, 2017-2022: a descriptive study.
Duan X; Zhang C; Wang X; Ren X; Peng H; Tang X; Zhang L; Chen Z; Ye Y; Zheng M; Zhong W; Chen X; Zeng Y; Yuan P; Long L
Emerg Microbes Infect; 2022 Dec; 11(1):2510-2519. PubMed ID: 36103331
[TBL] [Abstract][Full Text] [Related]
4. Effectiveness of Enterovirus 71 inactivated vaccines against hand, foot, and mouth disease: A test-negative case-control study.
Zhang Y; Cui J; Liu F; Song Y; Wang Q; Liu Y; Zhang Y; Li Z; Chang Z
Hum Vaccin Immunother; 2024 Dec; 20(1):2330163. PubMed ID: 38544389
[TBL] [Abstract][Full Text] [Related]
5. The epidemiological characteristics of enterovirus infection before and after the use of enterovirus 71 inactivated vaccine in Kunming, China.
Jiang H; Zhang Z; Rao Q; Wang X; Wang M; Du T; Tang J; Long S; Zhang J; Luo J; Pan Y; Chen J; Ma J; Liu X; Fan M; Zhang T; Sun Q
Emerg Microbes Infect; 2021 Dec; 10(1):619-628. PubMed ID: 33682641
[TBL] [Abstract][Full Text] [Related]
6. Enterovirus A71 vaccine effectiveness in preventing enterovirus A71 infection among medically-attended hand, foot, and mouth disease cases, Beijing, China.
Wang X; An Z; Huo D; Jia L; Li J; Yang Y; Liang Z; Wang Q; Wang H
Hum Vaccin Immunother; 2019; 15(5):1183-1190. PubMed ID: 30779680
[TBL] [Abstract][Full Text] [Related]
7. Enterovirus A71 Containing Codon-Deoptimized VP1 and High-Fidelity Polymerase as Next-Generation Vaccine Candidate.
Tsai YH; Huang SW; Hsieh WS; Cheng CK; Chang CF; Wang YF; Wang JR
J Virol; 2019 Jul; 93(13):. PubMed ID: 30996087
[TBL] [Abstract][Full Text] [Related]
8. Recent development of enterovirus A vaccine candidates for the prevention of hand, foot, and mouth disease.
Fang CY; Liu CC
Expert Rev Vaccines; 2018 Sep; 17(9):819-831. PubMed ID: 30095317
[TBL] [Abstract][Full Text] [Related]
9. Effectiveness of enterovirus A71 vaccine in severe hand, foot, and mouth disease cases in Guangxi, China.
Jiang L; Wang J; Zhang C; He W; Mo J; Zeng J; Chen M; Tan Y; Ning C
Vaccine; 2020 Feb; 38(7):1804-1809. PubMed ID: 31892446
[TBL] [Abstract][Full Text] [Related]
10. Is a multivalent hand, foot, and mouth disease vaccine feasible?
Klein M; Chong P
Hum Vaccin Immunother; 2015; 11(11):2688-704. PubMed ID: 26009802
[TBL] [Abstract][Full Text] [Related]
11. EV-A71 vaccine licensure: a first step for multivalent enterovirus vaccine to control HFMD and other severe diseases.
Mao Q; Wang Y; Bian L; Xu M; Liang Z
Emerg Microbes Infect; 2016 Jul; 5(7):e75. PubMed ID: 27436364
[TBL] [Abstract][Full Text] [Related]
12. Effectiveness of enterovirus A71 vaccine against pediatric HFMD and disease profile of post-vaccination infection.
Duan X; Zhang L; Ding L; Zhang C; Chen Z; Cheng Y; Wang X; Peng H; Tang X; Ren X; Liao J; Yang S; Zhu Y; Luo W; Zeng Y; Yuan P; Long L
Vaccine; 2024 Apr; 42(9):2317-2325. PubMed ID: 38433065
[TBL] [Abstract][Full Text] [Related]
13. Clinically isolated enterovirus A71 subgenogroup C4 strain with lethal pathogenicity in 14-day-old mice and the application as an EV-A71 mouse infection model.
Xu Y; Ma S; Zhu L; Huang Z; Chen L; Xu Y; Yin H; Peng T; Wang Y
Antiviral Res; 2017 Jan; 137():67-75. PubMed ID: 27864074
[TBL] [Abstract][Full Text] [Related]
14. Enhancing enterovirus A71 vaccine production yield by microcarrier profusion bioreactor culture.
Liu CC; Wu SC; Wu SR; Lin HY; Guo MS; Yung-Chih Hu A; Chow YH; Chiang JR; Shieh DB; Chong P
Vaccine; 2018 May; 36(22):3134-3139. PubMed ID: 28274636
[TBL] [Abstract][Full Text] [Related]
15. An enterovirus A71 virus-like particle with replaced loops confers partial cross-protection in mice.
Liu X; Zhu H; Wang M; Zhang N; Wang J; Tan W; Wu G; Yu P; Liu H; Liu Q
Virus Res; 2023 Nov; 337():199235. PubMed ID: 37788720
[TBL] [Abstract][Full Text] [Related]
16. Hand, foot and mouth disease and herpangina caused by enterovirus A71 infections: a review of enterovirus A71 molecular epidemiology, pathogenesis, and current vaccine development.
Chang YK; Chen KH; Chen KT
Rev Inst Med Trop Sao Paulo; 2018 Nov; 60():e70. PubMed ID: 30427405
[TBL] [Abstract][Full Text] [Related]
17. Hand, Foot, and Mouth Disease in China: Modeling Epidemic Dynamics of Enterovirus Serotypes and Implications for Vaccination.
Takahashi S; Liao Q; Van Boeckel TP; Xing W; Sun J; Hsiao VY; Metcalf CJ; Chang Z; Liu F; Zhang J; Wu JT; Cowling BJ; Leung GM; Farrar JJ; van Doorn HR; Grenfell BT; Yu H
PLoS Med; 2016 Feb; 13(2):e1001958. PubMed ID: 26882540
[TBL] [Abstract][Full Text] [Related]
18. Vaccine candidates generated by codon and codon pair deoptimization of enterovirus A71 protect against lethal challenge in mice.
Lee MHP; Tan CW; Tee HK; Ong KC; Sam IC; Chan YF
Vaccine; 2021 Mar; 39(12):1708-1720. PubMed ID: 33640144
[TBL] [Abstract][Full Text] [Related]
19. A novel mucosal bivalent vaccine of EV-A71/EV-D68 adjuvanted with polysaccharides from Ganoderma lucidum protects mice against EV-A71 and EV-D68 lethal challenge.
Lin YL; Cheng PY; Chin CL; Chuang KT; Lin JY; Chang N; Pan CK; Lin CS; Pan SC; Chiang BL
J Biomed Sci; 2023 Dec; 30(1):96. PubMed ID: 38110940
[TBL] [Abstract][Full Text] [Related]
20. Immunogenicity and safety of an inactivated enterovirus A71 vaccine in children 3-6 years and 2-35 months of age- an open-label, randomized phase IIb clinical trial.
Hung MC; Cho CY; Chen CJ; Lai CC; Wu KG
Vaccine; 2019 Sep; 37(37):5559-5566. PubMed ID: 31399275
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
